Detalles de la búsqueda
1.
Targeting KRASp.G12C Mutation in Advanced Non-Small Cell Lung Cancer: a New Era Has Begun.
Curr Treat Options Oncol
; 23(12): 1699-1720, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36394791
2.
Single agent VS-6766 or VS-6766 plus defactinib in KRAS-mutant non-small-cell lung cancer: the RAMP-202 phase II trial.
Future Oncol
; 18(16): 1907-1915, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35285277
3.
Autocrine 17-ß-Estradiol/Estrogen Receptor-α Loop Determines the Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer.
Clin Cancer Res
; 29(19): 3958-3973, 2023 10 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37285115
4.
Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research study.
Eur J Cancer
; 189: 112920, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37277262
5.
COVID-19 and Lung Cancer: A Comprehensive Overview from Outbreak to Recovery.
Biomedicines
; 10(4)2022 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35453526
6.
Prognostic factors in metastatic castration resistant prostate cancer patients treated with radium-223: a retrospective study.
Minerva Urol Nephrol
; 74(6): 703-713, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35147388
7.
A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma.
Crit Rev Oncol Hematol
; 172: 103639, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35192932
8.
Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer.
Cells
; 11(20)2022 10 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36291098
9.
Are tyrosine kinase inhibitors an effective treatment in testicular metastases from kidney cancer? Case report.
Tumori
; 107(6): NP149-NP154, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34761706
10.
Performing oncological procedures during COVID-19 outbreak: a picture from an Italian cancer center.
Explor Target Antitumor Ther
; 2(5): 481-489, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-36045703
11.
Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review.
Eur J Cancer
; 149: 49-60, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33823362
12.
Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide.
Minerva Urol Nephrol
; 73(6): 803-814, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33781017
13.
Prognostic role of the duration of response to androgen deprivation therapy in patients with metastatic castration resistant prostate cancer treated with enzalutamide or abiraterone acetate.
Prostate Cancer Prostatic Dis
; 24(3): 812-825, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33603237
14.
Renal cell carcinoma (RCC): fatter is better? A review on the role of obesity in RCC.
Endocr Relat Cancer
; 28(7): R207-R216, 2021 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33949971
15.
Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second wave.
Crit Rev Oncol Hematol
; 157: 103189, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33341505
16.
Overcoming the mechanisms of primary and acquired resistance to new generation hormonal therapies in advanced prostate cancer: focus on androgen receptor independent pathways.
Cancer Drug Resist
; 3(4): 726-741, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-35582226
17.
SARS-CoV-2 Infection in Cancer Patients: A Picture of an Italian Onco-Covid Unit.
Front Oncol
; 10: 1722, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32974210
18.
Local for advanced, is this a paradox?
Transl Lung Cancer Res
; 10(7): 3324-3328, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34430369
Resultados
1 -
18
de 18
1
Próxima >
>>